Ep 88 | Hospital Child Sites – Recent Developments with CMS Provider-Based Rules and 340B Child Site Eligibility Timing

Ep 92 | Latest 340B Updates

In this week’s episode, Greg and Rob discuss developments across the 340B community, including new manufacturer claims level data submission policies and ongoing discussion in Congress on 340B Program reform. Questions or comments? Email us at 340BUnscripted@spendmend.com!

Ep 91 | More 340B Updates

In this episode, Greg and Rob catch up on more recent developments across the 340B community. They discuss recent Congressional activity where 340B has been a focus, a shift in court rulings related to state contract pharmacy laws, and they catch up on recent litigation over 340B child site eligibility timing, GPO Prohibition policies, and patient definition. They round out the discussion by recapping developments with manufacturer contract pharmacy restrictions and claim-level data submission policies. Email us questions at 340BUnscripted@spendmend.com [340BUnscripted@spendmend.com]

Ep 90 | 340B Updates

In this episode, Greg and Rob catch up on various developments happening in the 340B community. Topics discussed include the proliferation of manufacturer claim submission requirements, notable court rulings and 340B-related lawsuits, and reactions to Congressional hearings that featured testimony related to 340B Program reform considerations. Got questions?  Email us at 340BUnscripted@spendmend.com!

Ep 89 | 340B Pricing Removal & GPO Prohibition Court Case Ruling

In this episode, Greg and Rob discuss reports of 340B pricing removal from wholesaler accounts, which may be related to recent manufacturer claim submission requirement policies.  They also catch up on some developments in state-level contract pharmacy laws, including Washington’s newly passed state law that incorporates contract pharmacy provisions, as well as reporting requirements for both providers and manufacturers. As a bonus, Nick Gnadt joins at the end to share an update on a recent court ruling (Premier v HHS) in which a judge vacated the 2013 HRSA GPO Prohibition Policy Notice. Premier, Inc. v HRSA DC District Court Ruling:  https://cases.justia.com/federal/district-courts/district-of-columbia/dcdce/1:2024cv03116/274475/23… [https://cases.justia.com/federal/district-courts/district-of-columbia/dcdce/1:2024cv03116/274475/23%E2%80%A6] Questions for us? Email us at 340BUnscripted@spendmend.com [340BUnscripted@spendmend.com]

Ep 88 | Hospital Child Sites – Recent Developments with CMS Provider-Based Rules and 340B Child Site Eligibility Timing

In this episode, Greg and Rob are joined by returning guest, healthcare attorney Jeff Davis. They’ll be discussing the CMS provider-based rule changes coming out of the 2026 Consolidated Appropriations Act, including the impact that these changes will have on 340B hospitals. They’ll also share some initial reactions to the Albany Medical Health System v. HHS court ruling out of the DC District Court, which has resulted in the vacating of HRSA’s policy notice from October 2023 that addressed 340B child site eligibility timing.